Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
November 01, 2021
Lawmakers on Capitol Hill extended a lifeline to US global response efforts with the provision of supplemental funding. Early on, sums dedicated to the overseas fight were modest, but last year's end-of-year spending package included $4 billion for Gavi, the Vaccine Alliance—to support the multilate...
Blog Post
October 28, 2021
We conducted a joint review of the portfolio management activities of the committee overseeing COVAX R&D and manufacturing investments, known as RDMIC (R&D and Manufacturing Investment Committee). Our aim was to assess learnings from investments to date and suggest ways to strengthen future ...
Oct
29
2021
9:00—10:15 AM EASTERN TIME (US AND CANADA)
October 14, 2021
In the Future of Development series, the Center for Global Development and the Georgetown University Initiative on Innovation, Development and Evaluation (gui2de) bring together development experts, scholars, and policymakers to address the big questions facing developing countries and help shape th...
Blog Post
October 13, 2021
The World Bank’s International Development Association (IDA), the largest single source of concessional financing for development in lower-income countries, is under-utilized in the world’s fight against pandemics, and can deploy its resources and expertise to play a much more significant role in th...
Blog Post
October 05, 2021
In this blog, we explore three key actions linked to strategic purchasing that India’s AB-PMJAY scheme can apply by leveraging its influence as a major purchaser of services and goods in the country. These same actions are readily generalizable and can replicated by other jurisdictions to save money...
Oct
4
2021
11:30—1:00 PM Washington DC Time
September 24, 2021
New research indicates there is a 47-57 percent chance of another global pandemic as deadly as COVID-19 occurring in the next 25 years. There is a clear need to more effectively prepare for future outbreaks, but what's the true return on investment?